18F-fluoroethylcholine (18F-Cho) PET/MRI functional parameters in pediatric astrocytic brain tumors

Francesco Fraioli1, Ananth Shankar, Darren Hargrave

  • 1From the *Department of Nuclear Medicine, and †Department of Paediatric and Adolescent Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom; ‡Department of Paediatric Oncology, Great Ormond Street Hospital, London, UK; §Department of Radiology University, and ¶Department of Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Clinical Nuclear Medicine
|September 5, 2014
PubMed
Abstract

Insights

Simultaneous F-choline PET/MRI shows promise for diagnosing and monitoring pediatric astrocytic brain tumors. This hybrid imaging approach effectively tracks changes in tumor size, metabolism, and diffusion during therapy.

Area of Science:

  • Pediatric oncology
  • Neuroimaging
  • Radiochemistry

Background:

  • Astrocytic brain tumors are a significant concern in pediatric oncology.
  • Accurate diagnosis and response assessment are crucial for effective treatment planning.
  • Current imaging modalities may have limitations in comprehensively evaluating tumor characteristics.

Purpose of the Study:

  • To evaluate the feasibility of simultaneous F-fluoroethylcholine (F-choline) PET and functional MRI acquisition.
  • To assess the utility of hybrid PET/MRI for diagnosis and treatment response monitoring in pediatric astrocytic tumors.
  • To correlate metabolic (SUV) and diffusion (ADC) parameters with tumor characteristics.

Main Methods:

  • 12 pediatric patients with astrocytic tumors underwent simultaneous F-choline PET/MRI scans.
  • Follow-up scans were performed in 8 patients post-treatment.
  • Tumor regions of interest were analyzed for maximum/mean standardized uptake values (SUVmax/mean) and mean apparent diffusion coefficient (ADCmean).
  • Spearman correlation assessed the association between ADCmean and SUV values.

Main Results:

  • Baseline F-choline uptake correlated with contrast enhancement and restricted diffusion.
  • Negative trend observed between SUVmax and ADCmean; positive trend between SUVmax and tumor size.
  • Concordance between reduced tumor size and decreased SUV values was noted in 4 children, with increased ADCmean in three.
  • Changes in SUV and ADC values indicated treatment response or progression in other patients.

Conclusions:

  • Simultaneous F-choline PET/MRI is a feasible and reliable imaging technique for pediatric astrocytic tumors.
  • This hybrid approach enables simultaneous monitoring of morphological and metabolic tumor changes.
  • It holds promise for assessing treatment response and guiding therapy in this patient population.

Related Concept Videos